Safety and toxicity concerns of orally delivered nanoparticles as drug carriers. Expert opinion on drug metabolism & toxicology, 11, 381-93.
(2015). Antihyperglycemic Potential of Incretins Orally Delivered via Nano and Microsystems and Subsequent Glucoregulatory Effects. Current Pharmaceutical Biotechnology, 15, 609-619.
(2014).